Who are Viveretx's investors?

Viveretx's investors include Berkeley Frontier.

Where is Viveretx headquartered?

Viveretx is headquartered in Berkeley, US.

Viveretx

Berkeley, US · Founded 2022 · 13 employees on LinkedIn · 1 known investors

Find your way into Viveretx

Paths you didn't know you had: your email and LinkedIn already hold routes to the Viveretx team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vivere is an early-stage biotech developing cancer therapies that use a bioengineering platform (based on UC Berkeley research) to activate the immune system against "cold" solid tumors through targeted delivery. It focuses on immuno-oncology and gene/viral vector engineering to treat difficult solid cancers.

Biotech Deep Tech Healthtech

Founders & leadership

Viveretx was founded in 2022 by Adam Schieferecke, Hyuncheol Lee, David Schaffer, John Dueber, and Wanichaya Noiwangklang.

Adam SchiefereckeCo-founder; Head of ResearchAdam Schieferecke has 13 years of experience in molecular, cellular, and evolutionary virology and serves as co-founder and head of research at Vivere, a biotech company developing cancer immunotherapies using viral vector engineering.

Hyuncheol LeeCo-founder; Head of Nonclinical DevelopmentHyuncheol Lee holds a DVM and PhD and has worked on immunology, virology, and gene therapy, with expertise in viral vector development and preclinical in vivo models for disease and cancer applications.

David SchafferCo-founder; PresidentExecutive Director of QB3, Director of Bakar Labs at Berkeley Frontier

John DueberCo-founder; Scientific Advisor

Wanichaya NoiwangklangCo-founder; Head of Operations

Investors · 1

Berkeley Frontierlisted by Berkeley FrontierBerkeley

How we know: the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does Viveretx do?: Vivere is an early-stage biotech developing cancer therapies that use a bioengineering platform (based on UC Berkeley research) to activate the immune system against "cold" solid tumors through targeted delivery. It focuses on immuno-oncology and gene/viral vector engineering to treat difficult solid cancers.
Who founded Viveretx?: Viveretx was founded by Adam Schieferecke, Hyuncheol Lee, David Schaffer, John Dueber, Wanichaya Noiwangklang in 2022.
Who are Viveretx's investors?: Viveretx's investors include Berkeley Frontier.
Where is Viveretx headquartered?: Viveretx is headquartered in Berkeley, US.